Dr. Cis Nicasy
ActiveSummary
Dr. Cis Nicasy has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €88k and a net result of €98k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 26% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
78
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency56▼-16
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €6k at 30 days acceptable
Liquidity tight (current ratio 1.18 against 1.33 in 2024; short-term debt: 69.3% and cash: 45.8% of total assets), and 69.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
30.7%
Return on assets
33.9%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-05-2026, 79 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
79 d early
2024
47 d early
2023
33 d early
2022
44 d early
2021
31 d early
2020
40 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Turnover
€238k
EBIT margin
42.9%
Net result
€98k▲ 41.1%
2024 · €69k
2020: €35k
2021: €80k
2022: €84k
2023: €70k
2024: €69k
2020 → 2025
Working capital
€35k▼ 10.9%
2024 · €39k
2020: €40k
2021: €121k
2022: €190k
2023: €212k
2024: €39k
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€238k-
Equity€121k-€204k▲ 69.3%€274k▲ 34.3%€110k▼ 60.0%€88k▼ 19.5%
Operating result€102k-€106k▲ 3.5%€89k▼ 16.1%€93k▲ 5.2%€126k▲ 34.9%
Net result€80k-€84k▲ 4.2%€70k▼ 16.3%€69k▼ 1.1%€98k▲ 41.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 35% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €288k
Fixed assets
€53k ▼ 24.3%
Current assets
€235k ▲ 46.1%
Equity and liabilities €288k
Equity
€88k ▼ 19.5%
Debt
€200k ▲ 64.6%
Debt's share of the balance-sheet total rises from 52.5% to 69.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€145k▲
2024 · €111k
Cash flow
€117k▲
2024 · €87k
Current ratio
1.18▼
2024 · 1.33
Debt to equity
2.26▲
2024 · 1.11
ROE
110.8%▲
2024 · 63.2%
ROA
33.9%▲
2024 · 30.0%
Interest coverage
228.80▲
2024 · 15.01
Debt ≤ 1 year
€200k▲
2024 · €121k
Income taxes
€28k▲
2024 · €18k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines
Balance sheet
Code20242025
Assets
Total assets20/58€231k€288k▲
Fixed assets21/28€70k€53k▼
Tangible fixed assets22/27€70k€53k▼
Land and buildings22€3k€3k▼
Plant, machinery and equipment23€11k€9k▼
Furniture and vehicles24€21k€8k▼
Other tangible fixed assets26€36k€34k▼
Current assets29/58€161k€235k▲
Amounts receivable within one year40/41€11k€18k▲
Trade receivables40€10k€10k▲
Other amounts receivable41€1k€7k▲
Current investments50/53€55k€85k▲
Cash at bank and in hand54/58€52k€132k▲
Deferred charges and accrued income490/1€43k-
Equity and liabilities
Total equity and liabilities10/49€231k€288k▲
Equity10/15€110k€88k▼
Contributions10/11€5k€5k=
Reserves13€105k€83k▼
Distributable reserves133€105k€83k▼
Amounts payable17/49€121k€200k▲
Amounts payable within one year42/48€121k€200k▲
Current portion of amounts payable after more than one year42€13k€13k▼
Trade debts44€6k€6k▲
Suppliers440/4€6k€6k▲
Taxes, remuneration and social security45€5k€10k▲
Taxes450/3€2k€8k▲
Remuneration and social security454/9€3k€3k▼
Other amounts payable47/48€97k€171k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€18k€20k▲
Other operating charges640/8€3k€1k▼
Gross operating margin9900€113k€147k▲
Operating profit (loss)9901€93k€126k▲
Financial income75/76B€1k€153▼
Recurring financial income75€1k€153▼
Financial charges65/66B€7k€635▼
Recurring financial charges65€7k€635▼
Profit (loss) for the period before taxes9903€87k€125k▲
Income taxes67/77€18k€28k▲
Profit (loss) for the period9904€69k€98k▲
Profit (loss) for the period to be appropriated9905€69k€98k▲
Appropriation of the result
Profit (loss) to be appropriated9906€69k€98k▲
Transfer from equity791/2€234k€119k▼
Transfer to equity691/2€69k€98k▲
To other reserves6921€69k€98k▲
Profit to be distributed694/7€234k€119k▼
Return on contributions (dividend)694€234k€119k▼
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
13-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2020net €98k ▲41.1%
Operating result €126k, net result €98k, both a record.
14-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
28-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
17-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Liquidity quadruplescurrent ratio 10.80
Current ratio from 2.68 to 10.80; short-term debt falls from €72k to €19k.
31-12
Financial
Equity above €200kEq €204k ▲69.3%
3 profitable years in a row build equity to €204k.
30-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Equity above €100kEq €121k ▲199%
2 profitable years in a row build equity to €121k.
21-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Geel · 1 establishment unit since 2019
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Luxemburglaan 272440 GeelGround area
3,095 m²
Building footprint
431 m²
Volume, LiDAR
2,134 m³
2 parcels, Flanders · tallest building 7.9 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Cis Nicasy
since 20192.295.968.026
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13372A0955/00X012 | Flanders | 1,785 m² | 1 · 191 m² | 7.9 m · 2 fl. |
| 13435D0732/00N005 | Flanders | 1,310 m² | 1 · 240 m² | 6.4 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. Sam Delvaux
BE 0773.946.667
Leuven · Eq €88,198
VanCor Huisartsen
BE 0741.417.619
Heusden-Zolder · Eq €88,174
CABINET de MEDECINE GENERALE du DOCTEUR SEBILLE
BE 0842.598.220
Marche-en-Famenne · Eq €88,148
Dr. Mattijs Govaerts, huisarts
BE 0774.970.513
Antwerpen · Eq €88,116
Dokter Lies Knippenberg
BE 0752.515.211
Maaseik · Eq €88,274
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,187 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded08-11-2019
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.